{"nct_id":"NCT04521621","title":"A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)","status":"TERMINATED","status_verified_date":"2024-09","start_date":"2020-10-28","start_date_type":"ACTUAL","primary_completion_date":"2023-07-25","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}